FORMULATIONS PHARMACEUTIQUES COMPRENANT UN AGONISTE DE RECEPTEUR D'OPIOIDE EN TANT QUE SUBSTANCES ACTIVES, LEURS PROCEDES DE FABRICATION ET LEURS UTILISATIONS THERAPEUTIQUES
The present invention concerns a pharmaceutical formulation in form of aqueous solution for sublingual and buccal administration, for the treatment of neonatal abstinence syndrome, said formulation comprising buprenorphine or a pharmaceutically acceptable salt thereof as the sole active ingredient, a viscosity enhancer, and a buffering agent in an amount to provide a pH of from 5.0 to 7Ø